. Effect of Orexins Injection into VMH on 2DG Uptake in Peripheral Tissues of Rats (A) The rate constant of 2DG uptake in peripheral tissues was measured 2 h after injection of low dose of orexin-A (0.5 pmol) into VMH. (B) The rate constant of 2DG uptake in peripheral tissues was measured 2 h after injection of orexin-B (5 pmol) or saline into VMH. All data are means ± SEM (n = 4-5). Error bars are shown as SEM. *P < 0.05, **P < 0.05 versus saline.
. Effect of Orexins Injection into VMH on 2DG Uptake in Peripheral Tissues of Rats (A) The rate constant of 2DG uptake in peripheral tissues was measured 2 h after injection of low dose of orexin-A (0.5 pmol) into VMH. (B) The rate constant of 2DG uptake in peripheral tissues was measured 2 h after injection of orexin-B (5 pmol) or saline into VMH. All data are means ± SEM (n = 4-5). Error bars are shown as SEM. *P < 0.05, **P < 0.05 versus saline.
Figure S2. Effects of Orexin-A Injection into VMH of WT Mice
(A) Time course of plasma glucose and insulin concentrations after the injection of orexin A (5 pmol) (n = 5). (B) Plasma glucose and insulin concentrations at 2 h after microinjection of orexin-A or saline into VMH (n = 7). (C) Food intake during the 2-h period immediately after injection of orexin-A or saline into VMH (n = 5). (D) Locomotor activity was measured every minute for 6 h after injection of orexin-A or saline into VMH (n = 6). Data are presented as total counts for each 30-min period. (E) Electromyograms of the back muscle of mice recorded for the indicated times after injection of orexin-A or saline into VMH. (F) Activity of α2AMPK in the soleus muscle at 2 h after injection of orexin-A or saline into VMH (n = 5). All quantitative data are means ± SEM. Error bars are shown as SEM.
Figure S3. Effects of β-AR Antagonists on Heart Rate and NE Turnover in WT Mice
(A) Effects of β-AR antagonists (1 mg/kg, i.p.) on the heart rate of WT mice (n = 3). *P < 0.05, **P < 0.01 versus time 0. (B) Effect of prior injection of the β2-AR antagonist ICI 118551 on NE turnover in soleus muscle induced by injection of orexin-A or saline into VMH of WT mice (n = 4 to 6). NE content was measured at 4 h after injection of α-methyl-p-tyrosine (α-MT, i.p.) and either orexin-A or saline. *P < 0.05 versus control untreated mice. Data are means ± SEM. Error bars are shown as SEM.
Figure S4. Effects of I.C.V. Injection of NPY or AgRP on 2DG Uptake in Skeletal Muscle of Mice
The rate constant of 2DG uptake in skeletal muscle of mice (n = 5) was measured 2 h after i.c.v. injection of NPY (0.5 nmol), AgRP (0.5 nmol), or saline. Data are means ± SEM. Error bars are shown as SEM.
Figure S5. Time Course of Plasma Glucose Concentration after Insulin Injection in Mice
The plasma glucose level was measured at the indicated times after i.v. injection of insulin together with glucose and with prior injection of orexin-A or saline into VMH as outlined in Figure 4A . Data are means ± SEM (n = 4). Error bars are shown as SEM.
Figure S6. Effect of Orexin-A on the Activity of Glycogen Phosphorylase a in the Soleus Muscle of Mice
Phosphorylase a activity in soleus muscle was measured 2 h after injection of orexin-A or saline into VMH. Data are expressed as the ratio of activity in the absence of AMP to that in its presence and are means ± SEM (n = 5). Data are means ± SEM. Error bars are shown as SEM.
Figure S7. Effects of Conditioned Saccharin Drinking in Mice
(A) Plasma glucose levels after insulin injection with or without prior saccharin (or water) drinking according to the protocol in Figure 6D were maintained constant by glucose injection (n = 7 to 9). (B) Rate constant of 2DG uptake in WAT after saccharin drinking and subsequent insulin injection as in Figure 6D (n = 7 to 9). *P < 0.05 versus control. (C) Plasma insulin levels after saccharin (or water) drinking and subsequent insulin injection as in Figure 6D (n = 4 or 5). Data are means ± SEM. Error bars are shown as SEM. One millimeter-thick sagittal sections of the entire mouse brain was dissected into PVH, ARH, VMH, DMH, and LH along the indicated blue lines. TH, thalamus. (C) mRNA levels of neuropeptides and transcriptional factor SF1 in dissected hypothalamic samples.
Supplemental Experimental Procedures

Surgical Operations for Animals
Mice were anesthetized by i.p. injection of ketamine (100 mg/kg) and xylazine (10 mg/kg), and a chronic double-walled stainless steel cannula was implanted stereotaxically and either unilaterally (right side) or bilaterally into VMH according to the atlas of Franklin and Paxinos (1997) .
The stereotaxic coordinates for VMH were AP 1.5 (1.5 mm anterior to the bregma), L 0.3 (0.3 mm lateral to the bregma), and H 5.8 (5.8 mm below the bregma). For injection of NPY or AgRP, a chronic double-walled stainless steel cannula was implanted into the lateral ventricle unilaterally; the stereotaxic coordinates were AP 0.3, L 1.0, and H 2.4. Cannulas were anchored firmly to the skull with acrylic dental cement.
Rats were anesthetized with pentobarbital sodium (50 mg/kg, i.p.), and a chronic double-walled stainless steel cannula was implanted stereotaxically and unilaterally into the right side of VMH, PVH, or LH according to the atlas of Paxinos and Watson. (1998) . The stereotaxic coordinates were AP 2.6 (2.6 mm anterior to the interaural line), L 0.4 (0.4 mm lateral to the sagittal suture), and H 9.5 (9.5 mm below the surface of the skull) for VMH; AP 1.8, L 0.3, and H 7.7 for the PVH; and AP 2.6, L 2.0, and H 9.0 for the LH.
Three days before determination of tissue glucose uptake or glycogen synthesis in rats or mice, a silicone catheter was implanted into the right atrium through the external jugular vein.
Animals were handled repeatedly during the recovery period (~2 weeks) after cannula implantation to habituate them to the injection and blood sampling procedures. All animal experiments were performed with animals in the fed condition with the exception of those involving oral glucose ingestion.
Correct placement of the cannula tips was verified microscopically in brain sections, with >95% of animals manifesting correct placement. Figure S8A is a photograph of coronal section of mouse hypothalamus accurately implanted brain cannula into the dorsomedial region of VMH. To verify the distribution of orexin-A in the hypothalamus after its injection, we dissected the ARH, VMH, DMH, PVH, and LH as described previously (Minokoshi et al., 2004) and measured orexin-A content with the use of an orexin-A enzyme immunoassay kit (Phoenix Pharmaceuticals, Burlingame, CA). The accuracy of dissection of hypothalamic nuclei was verified by mRNA expression of neuropeptides and transcriptional factor SF1 as described in Figure S8B another set of animals as described previously (Minokoshi et al., 2004) : pro-opiomelanocortin and NPY mRNAs for ARH, SF1 mRNA for VMH, corticotropin-releasing factor mRNA for PVH, orexin mRNA for LH and the absence of these various mRNAs for DMH ( Figure S8C ). Both sides of the ARH, VMH, DMH, or PVH were dissected from a 1-mm-thick sagittal section prepared from the midline of the fresh brain, and LH was dissected from the next 1-mm-thick sagittal section. The left side of each nucleus was used as a control. (provided by M. Morimatsu, Iwate University, Japan) were applied around the surface of the soleus muscle with the use of a microsyringe. Electric pulses were then administered six times at 70 V (loading period of 50 ms per pulse) from outside of the gastrocnemius with the use of an electroporator (CUY12; NEPA Gene, Ichikawa, Japan) and a pincette-type electrode (CUY650P, NEPA Gene). The left soleus and gastrocnemius muscles were subjected to the same electroporation procedure with the corresponding empty vector. During electroporation, the hind limb muscles were cooled with ice continuously. The mice were allowed to recover for 8 days before experiments.
Administration of Orexins
Analysis of EGFP expression was performed with skeletal muscle isolated 5 days after electroporation. The soleus and gastrocnemius muscles were frozen in liquid nitrogen-cooled isopentane and stored at −80°C until analysis. Cross-sections with a thickness of 10 μm were prepared, air-dried, and then analyzed for EGFP fluorescence by fluorescence microscopy (DMI4000B; Leica Microsystems, Wetzlar, Germany). Serial sections were stained with hematoxylin-eosin.
Experimental Protocol for Saccharin Drinking
Mice were trained for 3 days to drink saccharin solution spontaneously. The training was performed at 10:00 hours and consisted of supplying the animals with 1 ml of 10 mM saccharin (Sigma) solution.
Mice quickly became habituated to drinking the saccharin solution, so that on the day of the experiment they began to drink within 1 min and drank >0.8 ml within 10 min ( Figure 6C ). Control mice were also trained for 3 days to drink saccharin solution spontaneously, but, on the day of the experiment, they were provided with water instead of saccharin solution. The control animals also drank ~0.6 ml of the water within 10 min (data not shown). At 40 min after the onset of saccharin drinking, the mice were injected with insulin (0.75 U/kg, i.v.) and 20% glucose, followed 10 min later by injection of the radioisotopes for measurement of glucose uptake or glycogen synthesis.
Experimental Protocol for Oral Glucose Ingestion
Mice were habituated to oral ingestion of glucose solution for 3 days before the experiment. The training was performed at 16:00 hours and consisted of providing the mice with ~150 µl of 40% glucose solution (2 g/kg). Before the experiment, mice were deprived of food for 20 hours. At 16:00 hours on the day of the experiment, the animals were allowed to ingest the same amount of glucose (2 g/kg) orally with licking and tasting. A small amount of blood was collected from the tail at 0, 30, 60, 90, and 120 min after the onset of glucose ingestion. Blood glucose level was measured with a glucose analyzer (One Touch Ultra; Johnson & Johnson, Tokyo, Japan), and plasma insulin level was measured with a kit as described below.
Measurement of Whole-Body Glucose Turnover Rate
Basal whole-body glucose turnover rate (without insulin infusion) was measured in awake, concentration. We did not infuse nonradioactive glucose into rats because microinjection of orexin-A into VMH did not affect the plasma glucose level ( Figure 1A ; Table S1 ). Whole-body glucose turnover rate was calculated as the ratio of the [3-3 H]glucose infusion rate (dpm/min) to the specific activity of plasma glucose (dpm/µmol) as described previously (Rossetti and Giaccari, 1990 ) and based on the results obtained during the final 45 min of [3-3 H]glucose infusion; data are expressed as micromoles of glucose per kilogram of body mass per minute. The total volume of blood collected from each rat was <1 ml. At the end of the experiment, rats were killed by injection of an overdose of pentobarbital sodium (100 mg/kg).
Measurement of the Rate Constant of 2[ 3 H]DG Uptake in Peripheral Tissues
The rate constant of 2-[
H]deoxy-D-glucose (2[
3 H]DG) uptake in peripheral tissues was determined as described previously (Hom et al., 1984; Sudo et al., 1991 in 50 µl of saline was injected through the jugular vein catheter 2 h after the microinjection of orexin-A or 10 min after injection of insulin ( Figure 4A ). In the experiment featuring saccharin drinking, the same amounts of the radioisotopes were injected into mice 10 min after insulin injection (50 min after the onset of saccharin drinking) ( Figure 6D) . The catheter was then flushed immediately with 50 µl of saline. Blood was collected immediately before the injection of orexin, just before the injection of insulin, as well as 0, 10, 15, and 20 min after injection of the radioactive tracers.
Immediately after collection of the final blood sample, an overdose of pentobarbital sodium (100 mg/kg) was injected through the jugular vein catheter and the animals were rapidly decapitated.
Skeletal muscle (EDL, soleus, and red and white portions of the gastrocnemius) as well as epididymal (for rat and mouse) and retroperitoneal (for rat) WAT were rapidly dissected and weighed. Tissue samples were homogenized, the homogenates were centrifuged at 4°C, and the resulting supernatants as well as plasma samples were assayed for radioactivity. The rate constant of net tissue uptake of 2[ 3 H]DG was calculated as described previously (Hom et al., 1984; Sudo et al., 1991) .
Measurement of the Rate of Glycogen Synthesis in Skeletal Muscle
The rate of glycogen synthesis in skeletal muscle of mice was determined from the incorporation of 3 H radioactivity into muscle after i.v. injection of [3-3 H]glucose, as described previously (Rossetti and Giaccari, 1990) . Two hours after the microinjection of orexin-A or 10 min after injection of insulin, 10 µCi of [3-3 H]glucose (10 Ci/mmol) (American Radiolabeled Chemicals) dissolved in 50 µl of physiological saline were injected into mice through the jugular vein catheter. The catheter was then flushed immediately with 50 µl of saline. Blood was collected immediately before the injection of orexin, just before injection of insulin, as well as 0, 10, 15, and 20 min after injection of the radioactive tracer. Immediately after collection of the final blood sample, an overdose of pentobarbital sodium (100 mg/kg) was injected through the cardiac catheter, the mice were rapidly decapitated, and muscles were rapidly dissected and weighed. Muscle samples were homogenized and glycogen was extracted as described below, and the amount of radioactivity in the glycogen was determined. Plasma samples were dried and assayed for the amount of [3-3 H]glucose radioactivity.
The rate of glycogen synthesis in muscle was calculated by dividing the amount of 3 H radioactivity incorporated into muscle glycogen by the area under the curve for the disappearance of plasma [3-3 H]glucose; data are expressed as nanomoles of glucose per gram of tissue weight per minute. For the experiment featuring saccharin drinking, the same amount of radioisotope was injected into mice 10 min after insulin injection (50 min after the onset of saccharin drinking).
Measurement of Glycogen Content in Skeletal Muscle
Muscle was weighed and then homogenized in 0.5 M KOH at 95°C. Glycogen was precipitated by the addition to the homogenate of 3 volumes of ethanol and 0.1 volume of 6% Na 2 SO 4 at -80°C. The precipitate was washed with 70% ethanol, its content of glycogen was digested with amylo-1,4-1,6-glucosidase (2 mg/ml) (Sigma) in acetate buffer (pH 4.9), and the amount of glucose released was determined with a kit (Glucose CII-test; Wako, Osaka, Japan). Glycogen from rabbit liver (Sigma) was used as a standard. Data are expressed as micrograms of glycogen per milligram of tissue weight.
Measurement of Glycogen Synthase a Activity
Glycogen synthase activity was measured as described previously (Thomas et al., 1968) . Muscle tissue (10 mg) was homogenized on ice in 0.2 ml of extraction buffer [50 mM Hepes-NaOH (pH 7.5), 10 mM EDTA, 100 mM NaF, 1 µM leupeptin, 1 µM pepstatin, and 200 µM phenylmethylsulfonyl fluoride] with the use of a Polytron device at submaximal speed. The homogenate was centrifuged at 4°C, and the resulting supernatant was incubated for 20 min at 30°C with 0.3 mM [ 14 C]UDP-glucose (0.03 µCi) (American Radiolabeled Chemicals) and 1% glycogen in the absence or presence of 10 mM glucose 6-phosphate. Glycogen was then precipitated and washed as described above, and the amount of associated radioactivity was measured. Glycogen synthase activity was calculated as nanomoles of UDP-glucose incorporated into glycogen per minute per milligram of total protein.
Glycogen synthase a activity was expressed as the ratio of the activity determined in the absence of glucose 6-phosphate to that determined in its presence.
Measurement of Glycogen Phosphorylase a Activity
Glycogen phosphorylase a activity was measured as described previously (Gilboe et al., 1972) and is expressed as the ratio of activity in the absence of AMP divided by that in the presence of 3 mM AMP.
Measurement of Locomotor Activity and Food Intake
Food intake and spontaneous locomotor activity (horizontal movement) of mice or rats were measured automatically with the use of a multifaceted feeding and activity monitoring system (MFD-100W; Shintechno, Fukuoka, Japan). Both parameters were monitored continuously for 2 h or 6 h at the indicated times ( Figure 1F , Figure S2C ) after injection of orexin-A. All animals were habituated to the cage for 3 days before experiments.
Measurement of Plasma Glucose, Insulin, and Epinephrine Levels
Plasma concentrations of glucose (Glucose CII-test) and insulin (Insulin ELISA; Shibayagi, Gunma, Japan) were measured with the use of kits. Plasma epinephrine concentration was measured by high-performance liquid chromatography as described below for measurement of tissue NE content.
Recording of EMG and ECG
Mice were anesthetized with ketamine and xylazine, and small incisions were made on the back of the neck. A bipolar electrode for recording of the electromyogram (EMG) and a ground wire for the EMG and electrocardiogram (ECG) were inserted and tied to the back muscle. Two electrodes for the ECG were also tied to the left and right sides of the back muscle. The electrodes and ground wire were then attached to an electric connector and the connector was stitched to the skin of the neck. The mice were allowed to recover for at least 2 days. On the day of the experiment, recording wires were connected to the electric connector on the neck, and EMG and ECG recordings were initiated in conscious and unrestrained animals 10 min before the injection of β-AR antagonists or orexin-A. Amplified and filtered signals were stored and analyzed with the use of a personal computer and recording software (Data Acquisition System; Unique Medical, Tokyo, Japan).
Measurement of NE Turnover
NE turnover was measured on the basis of the decline in tissue NE content after the inhibition of catecholamine biosynthesis with α-methyl-p-tyrosine (α-MT) as described previously (Saito et al., 1989a) . Mice or rats were injected with orexin-A or SB334867 (or both) into VMH and then with α-MT (200 mg/kg, i.p.) (Sigma). At 0 and 4 h after α-MT injection, the animals were decapitated and tissues were rapidly removed and weighed. Tissue samples were homogenized in 0.2 M perchloric acid containing 0.1 mM EDTA, the homogenates were centrifuged at 4°C, and the NE content of the resulting supernatants was assayed by high-performance liquid chromatography (EP-300 system; Eicom, Kyoto, Japan) with a reversed-phase column (CA-5ODS, Eicom) and electrochemical detector (ECD-300, Eicom). Data are expressed as picograms of NE per milligram of tissue weight.
Electrophysiological Recording from VMH Neurons
Electrophysiological experiments were performed with 4-week-old C57BL/6J mice. Animals were anesthetized with halothane (Takeda, Osaka, Japan) and then killed by decapitation. The brain was rapidly removed and placed in ice-cold modified artificial cerebrospinal fluid (ACSF) containing 124 mM NaCl, 2.5 mM KCl, 1.1 mM NaH 2 PO 4 , 3.0 mM MgSO 4 , 1.0 mM CaCl 2 , 26 mM NaHCO 3 , and 12 mM glucose. Coronal slices (thickness, 250 µm) including VMH were cut with a vibratome (VT1000S; Leica, Nussloch, Germany), transferred to a holding tank containing modified ACSF, incubated at 32°C for 30 min, and then maintained at room temperature prior to recording.
Individual slices were transferred to a submerged recording chamber that was continuously perfused with ACSF at a flow rate of ~2 ml/min. The ACSF contained 128 mM NaCl, 3.0 mM KCl, 1.1 mM NaH 2 PO 4 , 1.2 mM MgCl 2 , 2.5 mM CaCl 2 , 26 mM NaHCO 3 , and 2.5 mM glucose, was bubbled with a gas mixture of 95% O 2 and 5% CO 2 , and was maintained at 30° to 32ºC. The slices were visualized by infrared differential interference contrast microscopy (Axioskop FS; Carl Zeiss, Jena, Germany) and photographed with a camera (C2400-07; Hamamatsu Photonics, Hamamatsu, Japan); the location of VMH was readily identifiable ( Figure 3C ). To quantify the effect of orexin-A on the firing rate or depolarization of VMH neurons, we set the membrane potential to -60 or -75 mV by current injection, respectively. VMH neurons in which the firing rate increased by >0.7 Hz from the basal value in response to application of orexin-A were regarded as orexin-sensitive neurons in Figure 3D . Stock solutions of orexin-A (Peptide Institute) and tetrodotoxin (Sankyo, Tokyo, Japan) were prepared in ACSF and stored at -20ºC.
These drugs were applied via a bath perfusion system. Orexin-A (500 nM) was applied for ~2 min, and tetrodotoxin (1 μM) was introduced for at least 5 min before orexin-A application.
Immunohistofluorescence Analysis of Hypothalamic Neurons
Mice were anesthetized with an overdose of pentobarbital sodium (80 mg/kg) and perfused with 10 ml of physiological saline followed by 40 ml of fixative consisting of 4% paraformaldehyde in phosphate-buffered saline (PBS). The brain was removed, trimmed, and immersed overnight at 4°C in the same fixative solution. After washing with PBS, the fixed brain was incubated at 4°C first for 1 day in PBS containing 20% (w/v) sucrose and then for an additional day in PBS containing 30% sucrose. The tissue was then embedded in OCT compound (Sakura Finetechnical, Tokyo, Japan), immediately frozen in liquid nitrogen-cooled isopentane, and stored at -80°C until analysis. Serial 7-µm-thick cryosections were prepared with the use of a cryostat (HM 500; Microm, Wolldorf, Germany), with the brain orientated for sectioning according to the mouse stereotaxic atlas (Franklin and Paxinos, 1997) .
For double immunohistofluorescence analysis of c-Fos and either orexin or MCH, brain sections were exposed for 1 h at room temperature to 10% normal horse serum and were then incubated overnight at 4°C with goat antibodies to orexin (1:2000 dilution) (Santa Cruz Biotechnology, Santa Cruz, CA) or chicken antibodies to MCH (1:4000) (Chemicon, Temecula, CA).
After washing of the sections with PBS, immune complexes were detected by incubation for 90 min at room temperature with Alexa 488-labeled donkey antibodies to goat immunoglobulin G (IgG) at a dilution of 1:400 (Molecular Probes, Eugene, OR) or with Alexa 488-labeled goat antibodies to chicken IgG (1:400) (Molecular Probes). The same sections were then incubated overnight at 4°C
with rabbit antibodies to c-Fos (1:20,000) (Ab-5; Oncogene, Cambridge, MA). After washing with PBS, the sections were incubated for 90 min at room temperature with Cy3-conjugated donkey antibodies to rabbit IgG (1:1000) (Chemicon). Sections were finally examined with a fluorescence microscope (AX-70; Olympus, Tokyo, Japan). Staining was absent in control sections processed without primary antibodies. Brain sections from mice subjected to drinking of saccharin or water were carefully matched on the basis of the shape of brain structures, and three sections corresponding to the LH (between 1.34 and 1.58 mm posterior to the bregma) (Franklin and Paxinos, 1997) were selected per mouse. Images from the selected sections were captured with a camera linked to a computer, and the number of c-Fos-positive neurons among a total of 120 orexin-positive cells per mouse was determined.
For double immunohistofluorescence analysis of orexin and SF1 in VMH of mice, brain sections were exposed for 1 h at room temperature to 10% normal horse serum and then incubated overnight at 4°C with goat antibodies to orexin (1:2000). After washing with PBS, the sections were incubated for 90 min at room temperature with Alexa 488-labeled donkey antibodies to goat IgG
